EcoDrugPlus

Leukotriene B4 Receptor

Ensembl ID : ENSCPOG00000014410
Gene Symbol: LTB4R
4 Cross references
141 Possible Orthologues:

Lysine Demethylase 1a

Ensembl ID : ENSCPOG00000010744
Gene Symbol: KDM1A
2 Cross references
214 Possible Orthologues:

Lysyl Oxidase Like 2

Ensembl ID : ENSCPOG00000009701
Gene Symbol: LOXL2
2 Cross references
288 Possible Orthologues:

Macrophage Migration Inhibitory Factor

Ensembl ID : ENSCPOG00000033496
Gene Symbol: MIF
2 Cross references
220 Possible Orthologues:

Macrophage Stimulating 1 Receptor

Ensembl ID : ENSCPOG00000002332
Gene Symbol: MST1R
4 Cross references
268 Possible Orthologues:

Maltase-Glucoamylase

Ensembl ID : ENSCPOG00000011280
Gene Symbol: MGAM
2 Cross references
312 Possible Orthologues:

Maltase-Glucoamylase 2 (Putative)

Ensembl ID : ENSCPOG00000009935
Gene Symbol: MGAM2
2 Cross references
393 Possible Orthologues:

Matrix Metallopeptidase 1

Ensembl ID : ENSCPOG00000006548
Gene Symbol: MMP1
4 Cross references
348 Possible Orthologues:

Matrix Metallopeptidase 12

Ensembl ID : ENSCPOG00000036913
Gene Symbol: MMP12
4 Cross references
560 Possible Orthologues:

Matrix Metallopeptidase 13

Ensembl ID : ENSCPOG00000000221
Gene Symbol: MMP13
4 Cross references
202 Possible Orthologues:

Matrix Metallopeptidase 14

Ensembl ID : ENSCPOG00000024551
Gene Symbol: MMP14
4 Cross references
272 Possible Orthologues:

Matrix Metallopeptidase 2

Ensembl ID : ENSCPOG00000020846
Gene Symbol: MMP2
2 Cross references
210 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).